NDC properties for NDC 9 0078-0494
NDC item 00078049461
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-61 |
| NDC Item | 00078049461 |
| packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
NDC item 00078049471
| NDC 9 | 0078-0494 |
|---|---|
| NDC 10 | 0078-0494-71 |
| NDC Item | 00078049471 |
| packaging | 56 POUCH in 1 CARTON (0078-0494-71) / 4 AMPULE in 1 POUCH (0078-0494-91) / 5 mL in 1 AMPULE (0078-0494-61) |
| FDA SPL set id | 644753 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 1997-12-22 |
| Marketing status | COMPLETED |
| NDA | NDA050753 |
NDC item 49502034573
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-73 |
| NDC Item | 49502034573 |
| packaging | 56 POUCH in 1 CARTON (49502-345-73) / 4 AMPULE in 1 POUCH (49502-345-99) / 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |
NDC item 49502034599
| NDC 9 | 49502-345 |
|---|---|
| NDC 10 | 49502-345-99 |
| NDC Item | 49502034599 |
| packaging | 4 in 1 POUCH |
| packaging | 5 mL in 1 AMPULE |
| FDA SPL set id | 859577 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA | NDA050753 |